Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Edoxaban in Anticoagulant Naïve Patients With Nonvalvular Atrial Fibrillation (NVAF) and High Creatinine Clearance

NCT02964949 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT02964949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02964949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Edoxaban in Anticoagulant Naïve Patients With Nonvalvular Atrial Fibrillation (NVAF) and High Creatinine Clearance
Lead sponsor
Daiichi Sankyo
Phase
Not applicable
Overall status
Completed
Start date
January 24, 2017
Completion date
October 9, 2018
Enrollment
607 (actual)
Sites
233

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation